Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • About us
    • About the Access Campaign
    • Media room
    • Latest news
    • Jobs

    Public support helps expand access to life-saving care and treatment.

    Sign up to stay updated and find out how you can get involved.

    I want to receive emails from MSF and I have read and agree with the privacy policy.

  • Our work
    • Drug-resistant infections
    • HIV/AIDS
    • Hepatitis C
    • Patents and intellectual property
      • The Patent Opposisions Database
      • Spotlight on: RCEP trade agreement
    • Research and development
    • Tropical and neglected diseases
      • Spotlight on: Snakebite
    • Tuberculosis
    • Vaccines
      • A Fair Shot campaign
    Wishlist 2019 - Catalogue

    Public support helps expand access to life-saving care and treatment.

    Sign up to stay updated and find out how you can get involved.

    I want to receive emails from MSF and I have read and agree with the privacy policy.

  • Get involved
    • Campaign success stories
      • A Fair Shot campaign
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    Take Action

    When you join one of our public campaigns, you work with MSF to save lives.

  • Resources
    • Events
    • Feature stories
    • Infographics
    • Interviews
    • Letters
    • Opinion articles
    • Photo stories
    • Press releases
    • Publications
      • Fact sheets
      • Issue briefs
      • Reports
      • Report series
      • Technical briefs
      • All types
    • Research articles
    • Statements
    • Topic overview pages
    • Spotlight pages
    • Videos

    Public support helps expand access to life-saving care and treatment.

    Sign up to stay updated and find out how you can get involved.

    I want to receive emails from MSF and I have read and agree with the privacy policy.

  • Media room
  • Contact
  • msf.org
  • About us
    • About the Access Campaign
    • Media room
    • Latest news
    • Jobs

    Public support helps expand access to life-saving care and treatment.

    Sign up to stay updated and find out how you can get involved.

    I want to receive emails from MSF and I have read and agree with the privacy policy.

  • Our work
    • Drug-resistant infections
    • HIV/AIDS
    • Hepatitis C
    • Patents and intellectual property
      • The Patent Opposisions Database
      • Spotlight on: RCEP trade agreement
    • Research and development
    • Tropical and neglected diseases
      • Spotlight on: Snakebite
    • Tuberculosis
    • Vaccines
      • A Fair Shot campaign
    Wishlist 2019 - Catalogue

    Public support helps expand access to life-saving care and treatment.

    Sign up to stay updated and find out how you can get involved.

    I want to receive emails from MSF and I have read and agree with the privacy policy.

  • Get involved
    • Campaign success stories
      • A Fair Shot campaign
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    Take Action

    When you join one of our public campaigns, you work with MSF to save lives.

  • Resources
    • Events
    • Feature stories
    • Infographics
    • Interviews
    • Letters
    • Opinion articles
    • Photo stories
    • Press releases
    • Publications
      • Fact sheets
      • Issue briefs
      • Reports
      • Report series
      • Technical briefs
      • All types
    • Research articles
    • Statements
    • Topic overview pages
    • Spotlight pages
    • Videos

    Public support helps expand access to life-saving care and treatment.

    Sign up to stay updated and find out how you can get involved.

    I want to receive emails from MSF and I have read and agree with the privacy policy.

Medicines shouldn’t be a luxury

Take action!
Get involved
The existing treatment lasts at least two years including several months in hospital. The treatment at the special drug resistant TB unit on the outskirts of Yerevan means having to take up to 20 pills a day, often together with painful injections every morning.

How is it possible...

...that we sent people to the moon almost 50 years ago, yet millions of people with tuberculosis are still treated with old, inadequate medicines?

https://tbsummit.msfaccess.org/
  • 1 result found
  • There are 2 active filters
  • Clear all filters
  • Tropical & neglected diseases
  • Interview
Filter by
Filters
Filter results

Date

Primary topics

All topics
  • Drug-resistant infections (2)
  • HIV/AIDS (2)
  • Intellectual property and trade (2)
  • Tropical & neglected diseases (1)
  • Tuberculosis (3)
  • Vaccines (2)

Types of content

All types
  • Events (16)
  • Feature story (37)
  • Infographic (3)
  • Interview (1)
  • Issue brief (13)
  • Letter (2)
  • Newsletter (2)
  • Opinion article (12)
  • Press release (61)
  • Report (9)
  • Research article (10)
  • Speech (8)
  • Statement (7)
  • Technical brief (3)
  • Video (34)

Products

All products
  • vaccines (1)

Diseases

All diseases
  • Ebola (1)
  • hemorrhagic fevers (1)
Apply
Clear all filters
1 results found
A nurse gives pain killers to a 12-years old girl staying in the Ebola isolation ward.
Interview |
12 August 2014

Ebola treatment - Interview with Dr Armand Sprecher, MSF doctor specialised in hemorrhagic fevers

Tags
Tropical & neglected diseases Ebolahemorrhagic fevers vaccines

Navigate

  • About the Access Campaign
  • Contact
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search

Get updates

  • Sign up for our newsletter
  • Privacy & data protection information

Contact

MSF Access Campaign
Médecins Sans Frontières
Rue de Lausanne 78
P.O Box 1016
CH-1211 Geneva 1, Switzerland
Phone:+41 22 849 8484 Fax:+41 22 849 8404
E-mail: access(at)msf.org

Follow us on Twitter and Facebook

  • Facebook
  • Twitter
  • Vimeo
Medicines Shouldn't Be A Luxury